• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Microbiol . Variation and Molecular Basis for Enhancement of Receptor Binding of H9N2 Avian Influenza Viruses in China Isolates

tetano

Editor, Senior Moderator
Front Microbiol


. 2020 Dec 17;11:602124.
doi: 10.3389/fmicb.2020.602124. eCollection 2020.
Variation and Molecular Basis for Enhancement of Receptor Binding of H9N2 Avian Influenza Viruses in China Isolates


Yang Liu[SUP] 1 2 3 4 [/SUP], Shuo Li[SUP] 1 2 3 4 [/SUP], Huapeng Sun[SUP] 1 2 3 4 [/SUP], Liangqi Pan[SUP] 1 2 3 4 [/SUP], Xinxin Cui[SUP] 1 2 3 4 [/SUP], Xuhui Zhu[SUP] 1 2 3 4 [/SUP], Yaling Feng[SUP] 1 2 3 4 [/SUP], Mingliang Li[SUP] 1 2 3 4 [/SUP], Yanan Yu[SUP] 1 2 3 4 [/SUP], Meihua Wu[SUP] 1 2 3 4 [/SUP], Jiate Lin[SUP] 1 2 3 4 [/SUP], Fengxiang Xu[SUP] 1 2 3 4 [/SUP], Shaohua Yuan[SUP] 1 2 3 4 [/SUP], Shujian Huang[SUP] 5 [/SUP], Hailiang Sun[SUP] 1 2 3 4 [/SUP], Ming Liao[SUP] 1 2 3 4 [/SUP]



Affiliations
Free PMC article

Abstract

Currently, H9N2 avian influenza viruses (H9N2 AIVs) globally circulate in poultry and have acquired some adaptation to mammals. However, it is not clear what the molecular basis is for the variation in receptor-binding features of the H9N2 AIVs. The receptor-binding features of 92 H9N2 AIVs prevalent in China during 1994-2017 were characterized through solid-phase ELISA assay and reverse genetics. H9N2 AIVs that circulated in this period mostly belonged to clade h9.4.2. Two increasing incidents occurred in the ability of H9N2 AIVs to bind to avian-like receptors in 2002-2005 and 2011-2014. Two increasing incidents occurred in the strength of H9N2 AIVs to bind to human-like receptors in 2002-2005 and 2011-2017. We found that Q227M, D145G/N, S119R, and R246K mutations can significantly increase H9N2 AIVs to bind to both avian- and human-like receptors. A160D/N, Q156R, T205A, Q226L, V245I, V216L, D208E, T212I, R172Q, and S175N mutations can significantly enhance the strength of H9N2 AIVs to bind to human-like receptors. Our study also identified mutations T205A, D208E, V216L, Q226L, and V245I as the key sites leading to enhanced receptor binding of H9N2 AIVs during 2002-2005 and mutations S119R, D145G, Q156R, A160D, T212I, Q227M, and R246K as the key sites leading to enhanced receptor binding of H9N2 AIVs during 2011-2017. These findings further illustrate the receptor-binding characteristics of avian influenza viruses, which can be a potential threat to public health.

Keywords: H9N2 AIV; HA; influenza; receptors binding site; variation.
 
Back
Top Bottom